Cardiovascular Disease

Unraveling the Vaccine-Myocarditis Mystery

It’s pretty clear that myocarditis is a rare complication of the mRNA COVID vaccine. A new study published in Circulation suggests this phenomenon may be related to vaccine-generated spike proteins that dodged antibodies.

Researchers matched 16 children with post-vaccine myocarditis to 45 control children who had been vaccinated without complication: 

  • Absolute antibody titers were no different in the myocarditis vs. the control group.
  • Autoantibody levels were also similar in both groups.
  • T-cell responses were mostly similar–except for one T-cell subtype that was slightly elevated in the myocarditis group. 
  • Inflammatory markers (including interleukin cytokines, TNF-α, and INF-γ,) were significantly higher in the myocarditis group. 

Most importantly, the researchers found free spike protein in the blood (not bound by anti-spike antibodies) present in 12 out of the 16 patients with myocarditis, but in *zero* of the 45 control patients. This suggests that these vaccine-generated spike proteins may be the driving force behind mRNA vaccine-related myocarditis in young people.

The Takeaway

The incidence of myocarditis among children infected with SARS-CoV-2 is still much higher than the risk of post-vaccination myocarditis, and these results do not negate the overall efficacy of mRNA vaccines in preventing severe COVID outcomes. 

But we are still left with the puzzling question: Why do some people completely clear the spike protein, while others do not? The search for answers continues. 

Get the top cardiology stories right in your inbox

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team